当前位置:首页 - 行情中心 - 康弘药业(002773) - 财务分析 - 现金流量表

康弘药业

(002773)

  

流通市值:150.06亿  总市值:201.31亿
流通股本:6.87亿   总股本:9.21亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,172,035,090.594,967,274,679.873,867,965,865.992,569,837,866.6
  收到其他与经营活动有关的现金20,849,109.98128,802,523.9118,373,151.6778,317,067.04
  经营活动现金流入小计1,192,884,200.575,096,077,203.773,986,339,017.662,648,154,933.64
  购买商品、接受劳务支付的现金83,183,428.62310,805,097.09209,154,428.35137,231,441.85
  支付给职工以及为职工支付的现金370,214,374.441,301,289,008.41,001,232,591.36661,230,983.58
  支付的各项税费138,049,510.14434,846,130.68329,038,713.95244,126,567.07
  支付其他与经营活动有关的现金257,126,175.991,545,488,514.881,038,637,595.98689,779,620.04
  经营活动现金流出小计848,573,489.193,592,428,751.052,578,063,329.641,732,368,612.54
  经营活动产生的现金流量净额344,310,711.381,503,648,452.721,408,275,688.02915,786,321.1
二、投资活动产生的现金流量:
  收回投资收到的现金-5,955,000,0003,240,000,0002,640,000,000
  取得投资收益收到的现金-36,883,259.6511,533,310.238,353,588.76
  处置固定资产、无形资产和其他长期资产收回的现金净额27,567.61214,808.0977,489.7653,154.66
  收到的其他与投资活动有关的现金-1,270,000860,000600,000
  投资活动现金流入小计27,567.615,993,368,067.743,252,470,799.992,649,006,743.42
  购建固定资产、无形资产和其他长期资产支付的现金69,554,905.95262,480,608.58179,453,898.1174,295,030.49
  投资支付的现金440,000,0005,955,000,0005,805,000,0005,305,000,000
  支付其他与投资活动有关的现金200,0001,254,000650,000430,000
  投资活动现金流出小计509,754,905.956,218,734,608.585,985,103,898.115,379,725,030.49
  投资活动产生的现金流量净额-509,727,338.34-225,366,540.84-2,732,633,098.12-2,730,718,287.07
三、筹资活动产生的现金流量:
  吸收投资收到的现金-35,067,48535,047,48529,342,742.5
  其中:子公司吸收少数股东投资收到的现金-1,830,0001,810,000270,000
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-35,067,48535,047,48529,342,742.5
  分配股利、利润或偿付利息支付的现金-552,673,862.4552,673,862.4552,673,862.4
  支付其他与筹资活动有关的现金1,267,868.411,916,316.571,485,890.361,617,120.15
  筹资活动现金流出小计1,267,868.41554,590,178.97554,159,752.76554,290,982.55
  筹资活动产生的现金流量净额-1,267,868.41-519,522,693.97-519,112,267.76-524,948,240.05
四、汇率变动对现金及现金等价物的影响-157,509.87-482,965.57-551,595.52-2,359.72
五、现金及现金等价物净增加额-166,842,005.24758,276,252.34-1,844,021,273.38-2,339,882,565.74
  加:期初现金及现金等价物余额6,383,703,498.95,625,427,246.565,625,427,246.565,625,427,246.56
  期末现金及现金等价物余额6,216,861,493.666,383,703,498.93,781,405,973.183,285,544,680.82
补充资料:
  净利润-1,145,503,613.71-721,864,033.83
  资产减值准备-7,985,713.08-1,199,917.99
  固定资产和投资性房地产折旧-199,296,374.84-99,096,017.62
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-199,296,374.84-99,096,017.62
  无形资产摊销-37,074,895.78-16,672,349.14
  长期待摊费用摊销-5,789,209.17-1,979,204.7
  处置固定资产、无形资产和其他长期资产的损失--9,782.42--3,472.82
  固定资产报废损失-598,226.96-257,117.33
  公允价值变动损失--550,600-1,884,200
  财务费用-402,269.43-317,709.81
  投资损失--36,236,443.63--8,123,311.62
  递延所得税-127,152,034.56-80,711,773.66
  其中:递延所得税资产减少-130,605,127.48-83,580,674.79
    递延所得税负债增加--3,453,092.92--2,868,901.13
  存货的减少--22,160,586.1-12,793,834.18
  经营性应收项目的减少--3,007,100.78--33,799,903.82
  经营性应付项目的增加-37,988,875.41-17,438,381.06
  其他-2,052,907.36-2,600,399.42
  现金的期末余额-6,383,703,498.9-3,285,544,680.82
  减:现金的期初余额-5,625,427,246.56-5,625,427,246.56
  现金及现金等价物的净增加额-758,276,252.34--2,339,882,565.74
公告日期2026-04-232026-04-232025-10-292025-08-28
审计意见(境内)标准无保留意见
TOP↑